Menu
 

Search abstracts


Comparative effectiveness and safety between dabigatran and rivaroxaban in routine practice

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: CHIOU, Chun-Chi (Kaohsiung Chang Gung Memorial Hospital, Department of Pharmacy)
  • Co-author(s): Chun-Chi Chiou: Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Province of China
    Chien-Ning Hsu: Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Province of China
    Ching-Ling Tai: Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Province of China
    Yu-Chin Wang: Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Province of China
  • Abstract:

    Background

    There are conflicting opinions regarding the efficacy and safety of NOACs in Asian population with atrial fibrillation (AF).

    Methods

    AF patients newly (no prior oral anticoagulants ≤ 180 days) initiated with warfarin (n=5981), dabigatran (n=1609) or rivaroxaban (n=2525) were identified using electronic medical records derived from the

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses